Evofem Biosciences Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 0
Bid Price 0.465
Ask Price 0.468
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Evofem Biosciences Inc EVFM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.4782 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.4782 0.4782
Trades Volume Avg Volume 52 Week Range
0 0 - 0.1104 - 1.57
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.4782 USD


Draw Mode:

Evofem Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 39.43M 82.45M 82.26M $ 8.24M $ - -24.36 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
8.68M $ - - 171.00k 7.60%

more financials information »

Evofem Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EVFM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.051.110.430.683215433,861,672-0.5718-54.46%
1 Month1.041.110.430.817057423,489,320-0.5618-54.02%
3 Months0.4951.570.2750.98598339,784,950-0.0168-3.39%
6 Months0.41911.570.11040.931058619,754,4270.059114.1%
1 Year0.82091.570.11040.873010111,574,776-0.3427-41.75%
3 Years5.058.990.11041.336,150,677-4.57-90.53%
5 Years11.8112.560.11041.354,099,641-11.33-95.95%

Evofem Biosciences Description

Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.

Your Recent History
Evofem Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now